Medifocus Inc

0.0001-0.0001-50.00%Vol 10.00K1Y Perf -95.00%
Nov 16th, 2021 12:38
BID0.0000 ASK0.0000
Open0.0001 Previous Close0.0002
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     37.33
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
0.00 
Earnings Rating
Market Cap18.50K 
Earnings Date
-
Alpha0.00 Standard Deviation0.58
Beta5.38 

Today's Price Range

0.00010.0001

52W Range

0.00010.0162

5 Year PE Ratio Range

-1.5000-1.3000

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.00%
1 Month
0.00%
3 Months
-96.43%
6 Months
-98.31%
1 Year
-95.00%
3 Years
-99.52%
5 Years
-99.37%
10 Years
0.00%

TickerPriceChg.Chg.%
MDFZF0.0001-0.0001-50.00
AAPL160.763.95002.52
GOOG2 930.2374.11002.59
MSFT337.357.67002.33
XOM62.120.87001.42
WFC49.310.88001.82
JNJ159.940.74000.46
FB339.826.70002.01
GE98.981.14001.17
JPM161.990.06000.04
Earnings HistoryEstimateReportedSurprise %
Q03 2020-0.00-
Q01 2020-0.00-
Q04 2019-0.00-
Q03 2019-0.00-
Q02 2019-0.00-
Q01 2019-0.00-
Q04 2018--0.01-
Q02 2018-0.00-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume10.00K
Shares Outstanding184.98M
Shares Float184.98M
Trades Count1
Dollar Volume1
Avg. Volume67.51K
Avg. Weekly Volume32.48K
Avg. Monthly Volume45.91K
Avg. Quarterly Volume71.35K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Medifocus Inc

Medifocus INC develops and sells minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostate Hyperplasia (BHP). It owns two focused heat technology platforms, The Endo-thermotherapy Platform-from which Prolieve was developed, can be used to treat cancers in prostate, rectal, cervical and esophageal, and The Adaptive Phased Array Microwave Focusing Platform which directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The company through its operations generates revenue from the United States.

CEO: William W. Jow

Telephone: +1 410 290-5734

Address: 10240 Old Columbia Road, Columbia 21046, MD, USA

Number of employees: 9

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

47%53%

Bearish Bullish

63%38%

News